Pol F. Boudes

Chief Medical Officer, Amicus Therapeutics.

Companies

Protalix Biotherapeutics IncBoard member Jan 3, 2020 to now¹
GALECTIN THERAPEUTICS INCChief Medical Officer Mar 16, 2020 to Feb 7, 2024²
CymaBay Therapeutics (United States)Chief Medical Officer Apr 3, 2014 to Jan 31, 2019³
Amicus TherapeuticsChief Medical Officer Jan 29, 2009 to Jun 6, 2012⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Protalix Biotherapeutics Inc PLX7,540 shares⁵$20.5K at $2.71Sep 4, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 3, 2025Granted 7,500 shares of Protalix Biotherapeutics Inc⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARProtalix Biotherapeutics Inc, Board member
2
SEC EDGARGALECTIN THERAPEUTICS INC, Chief Medical Officer
3
SEC EDGARCymaBay Therapeutics (United States), Chief Medical Officer
4
SEC EDGARAmicus Therapeutics, Chief Medical Officer
5
SEC EDGARProtalix Biotherapeutics Inc shares after the filing of Sep 4, 2025